21 results
8-K
EX-99.1
IKNA
Ikena Oncology Inc
7 Aug 23
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
8:02am
. Our attraction to Ikena was driven by not only the potential of their targeted oncology programs, but by their company culture and the way
8-K
EX-99.1
yk6s 4804
19 Dec 22
Ikena Oncology Appoints Owen Hughes as Board Chair
4:41pm
DEF 14A
p3gx2uzevl
27 Apr 22
Definitive proxy
4:32pm
10-K
hsxgyk3bp
17 Mar 22
Annual report
6:31am
10-Q
q9m3v8wg
13 May 21
Quarterly report
4:15pm
424B4
lekrzoqgmkxzq72pixs
26 Mar 21
Prospectus supplement with pricing info
5:04pm
S-1/A
vbnd4ajtmncp ki861
22 Mar 21
IPO registration (amended)
8:51am
S-1
pp7dy6n jlh
5 Mar 21
IPO registration
2:59pm
DRS/A
qjpcrxp 6mhmeq
11 Feb 21
Draft registration statement (amended)
12:00am